ClinicalTrials.Veeva

Menu

Telomere Length and Other Parameters of Telomere Dysfunction in PSC and Colitis

Clalit Health Services logo

Clalit Health Services

Status

Unknown

Conditions

Primary Sclerosing Cholangitis
Inflammatory Bowel Disease

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

PSC is a chronic cholestatic disorder. The investigators intend to study some telomere parameters and telomere length in order to predict a premalignant state.

Full description

Primary sclerosing cholangitis (PSC) and colitis are chronic inflammatory disorders with malignant potential. Telomerase is an enzyme complex that lengthens telomeres and has enhanced expression in numerous malignancies. In this study, we evaluated the telomerase gene copy number, telomere length, cells in senescence, aneuploidy and additional parameters of telomere dysfunction from peripheral blood lymphocytes of patients.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • informed consent
  • documented PSC and inflammatory bowel disease

Exclusion criteria

  • under 18 years, above 80 y
  • known active malignancy
  • decompensated cirrhosis
  • patients who cannot sign informed consent

Trial design

60 participants in 3 patient groups

Healthy control
IBD
Description:
patients with inflammatory bowel disease, study group
PSC
Description:
patients with primary sclerosing cholangitis, study group

Trial contacts and locations

1

Loading...

Central trial contact

Ido Laish, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems